InMode (INMD) Cash from Investing Activities Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | 44.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.54% |
| Dec 31, 2025 | -65.02% |
| Sep 30, 2025 | -89.77% |
| Jun 30, 2025 | 304.27% |
| Mar 31, 2025 | 259.28% |
| Dec 31, 2024 | 250.84% |
| Sep 30, 2024 | 263.35% |
| Jun 30, 2024 | 36.27% |
| Mar 31, 2024 | -71.98% |
| Dec 31, 2023 | -34.79% |
| Sep 30, 2023 | -24.39% |
| Jun 30, 2023 | 647.89% |
| Mar 31, 2023 | -117.11% |
| Dec 31, 2022 | -24.24% |
| Sep 30, 2022 | -16.60% |
| Jun 30, 2022 | 94.55% |
| Mar 31, 2022 | 66.25% |
| Dec 31, 2021 | -16.78% |
| Sep 30, 2021 | -77.92% |
| Jun 30, 2021 | -347.30% |
| Mar 31, 2021 | -402.98% |
| Dec 31, 2020 | 16.53% |
| Sep 30, 2020 | 57.43% |
| Jun 30, 2020 | 304.84% |
| Mar 31, 2020 | 13.99% |
| Dec 31, 2019 | -494.99% |
| Sep 30, 2019 | -224.36% |
| Jun 30, 2019 | -202.71% |